City

Chicago (2)

Condition

Dry Eye (2)

Ocular Graft vs Host Disease (2)

Meibomian Gland Dysfunction (1)

Overall Status

Terminated (2)

Sign in for free

Phase

phase 1/phase 2 (2)

Sponsor

Sandeep Jain, MD (1)

University of Illinois at Chicago (1)

Collaborator

Genentech, Inc. (1)

National Eye Institute (NEI) (1)

Ocugen (1)

Intervention

brimonidine 0.075% (1)

brimonidine 0.15% (1)

placebo (1)

rhdnase i (1)

vehicle (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (2)

Study Type

Interventional (2)

ocular graft vs host disease

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Ocular GVHD, Dry Eye Trial in Chicago (rhDNase I, Vehicle)

Terminated

Has Results

Ocular Graft vs Host Disease
Dry Eye

rhDNase I
Vehicle

Chicago, Illinois
+1 more

Aug 10, 2021

Dry Eye, Ocular GVHD, Meibomian Gland Dysfunction Trial in Chicago (Brimonidine 0.15%, Brimonidine 0.075%, Placebo)

Terminated

Has Results

Dry Eye
+2 more

Brimonidine 0.15%
+2 more

Chicago, Illinois
+1 more

Nov 7, 2019